Welcome to the investors section of Adocia  

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.


Latest Press Releases
2017/05/19Adocia to hold its annual shareholders’ meeting on June 27, 2017 in Paris
Read more
2017/04/18Adocia announces the release of its Reference Document, containing the Annual Financial Report and the Management Report, for the year 2016
Read more

All Press releases

Next events

30 mai 2017 15th Healthcare Midcaps Forum – Gilbert Dupont Bank brokerage firm – Paris, France - Some thirty Midcaps, representative of the health sector, will meet with a large population of Institutional and Private Managers of the strategy and prospects of their company
See event

All events